effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) at the end of the period covered by this report and, based on such evaluation, have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.
Changes in internal control over financial reporting.
There have been no changes in our internal control over financial reporting that occurred during our second quarter of fiscal 2025 that have materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
37
Table of Contents
PART II. OTHER INFORMATION
See
Note 13—Legal Matters
to the unaudited consolidated financial statements included in this Form 10-Q for developments concerning the Company’s current material legal proceedings, since the Company's Annual Report on Form 10-K for the year ended September 30, 2024.
For a discussion of the Company’s risk factors, see the information under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended September 30, 2024.
38
Table of Contents
Issuer Purchases of Equity Securities
The table below presents our purchases of class A common stock for the three months ended March 31, 2025:
(1)
Includes applicable taxes.
See
Note 9—Stockholders’ Equity
to our unaudited consolidated financial statements for further discussion on our share repurchase programs.
None.
Not applicable.
(c) Trading Plans
For the three months ended March 31, 2025, the following officer adopted a Rule 10b5-1 trading arrangement as defined in Regulation S-K Item 408, which is intended to satisfy the affirmative defense in Rule 10b5-1(c), as follows:
On
March 5, 2025
,
Rajat Taneja
, our
President, Technology
,
adopted
a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to
190,856
shares of our class A common stock, including shares issuable upon the vesting of performance shares. The duration of the trading arrangement is until
May 22, 2026
or earlier if all transactions under the trading arrangement are completed.
No other officers or directors
adopted
and/or
terminated
a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement for the three months ended March 31, 2025.
39
Table of Contents
EXHIBIT INDEX
40
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
41